These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9296063)
41. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847 [TBL] [Abstract][Full Text] [Related]
42. The George M. Kober lecture: a genetical view of modern medicine. Motulsky AG Trans Assoc Am Physicians; 1977; 90():76-90. PubMed ID: 565552 [TBL] [Abstract][Full Text] [Related]
43. [Predictive medicine--ethical and social aspects of genetic diagnosis]. Bayertz K Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):M55-7. PubMed ID: 8682278 [No Abstract] [Full Text] [Related]
44. Ethical, social and counselling issues in hereditary cancer susceptibility. Garber JE; Patenaude AF Cancer Surv; 1995; 25():381-97. PubMed ID: 8718528 [TBL] [Abstract][Full Text] [Related]
45. [Diabetes and predictive medicine--parallax of the present time]. Rybka J Vnitr Lek; 2010 Apr; 56(4):269-79. PubMed ID: 20465094 [TBL] [Abstract][Full Text] [Related]
46. [Possibilities and problems created by the development in human genetics]. Van den Berghe H Verh K Acad Geneeskd Belg; 1996; 58(4):339-56; discussion 356-8. PubMed ID: 8984803 [TBL] [Abstract][Full Text] [Related]
47. The control and propagation of a genetic disease. Isely DC ISA Trans; 1976; 15(2):115-21. PubMed ID: 977272 [TBL] [Abstract][Full Text] [Related]
48. Ethical boundaries in genetic testing. Allan D CMAJ; 1996 Jan; 154(2):241-4. PubMed ID: 8548713 [TBL] [Abstract][Full Text] [Related]
49. [Ethical problems in molecular genetics and their reflection in clinical medicine]. Pullmann R; Bosmanský K; Sámel M Vnitr Lek; 1997 Mar; 43(3):131-6. PubMed ID: 9221570 [TBL] [Abstract][Full Text] [Related]
50. The role of the human genome project in disease prevention. Gottesman MM; Collins FS Prev Med; 1994 Sep; 23(5):591-4. PubMed ID: 7845920 [TBL] [Abstract][Full Text] [Related]
51. Panel One: marketing strategies and informing the patient/consumer. Infertility diagnostic techniques: the rush to market. Kent-First MG Womens Health Issues; 1997; 7(3):176-80; discussion 186-7. PubMed ID: 9203865 [TBL] [Abstract][Full Text] [Related]
52. [Genetic examinations in health care]. Indulski JA; Lutz W Med Pr; 1996; 47(5):475-84. PubMed ID: 9026628 [TBL] [Abstract][Full Text] [Related]
53. [Patient without being ill? Benefit and risks of presymptomatic diagnosis]. Müller HJ Schweiz Rundsch Med Prax; 1993 Jan; 82(2):45-9. PubMed ID: 8424138 [TBL] [Abstract][Full Text] [Related]
54. From bench to bedside--the impact of the transfer of the new biology to clinical medicine. Burrow GN Clin Invest Med; 1988 Aug; 11(4):315-20. PubMed ID: 3168354 [TBL] [Abstract][Full Text] [Related]
55. The limits of genetic inquiry. Lappé M Hastings Cent Rep; 1987; 17(4):5-10. PubMed ID: 3478324 [TBL] [Abstract][Full Text] [Related]
56. [Predictive medicine: an ethical challenge to medical practice]. Frontali M; Jacopini AG Ann Ist Super Sanita; 1998; 34(2):237-43. PubMed ID: 9810748 [TBL] [Abstract][Full Text] [Related]
58. Genetic analysis of complex disease--a roadmap to understanding or a colossal waste of money. Glaser B Pediatr Endocrinol Rev; 2010; 7(3):258-65. PubMed ID: 20526239 [TBL] [Abstract][Full Text] [Related]
59. [Coronary artery disease from a perspective of genomic risk score, ethical approaches and suggestions]. Ağırbaşlı D; Ülman YI Anadolu Kardiyol Derg; 2012 Mar; 12(2):171-7. PubMed ID: 22306571 [TBL] [Abstract][Full Text] [Related]